Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 9.15M | 9.60M | +441.8K (+4.8%) |
| Value | $16.5M | $19.8M | +$3.29M (+20.0%) |
New holders (3)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 50,800 | $104.6K | 0.00% |
| Marco Investment Management LLC | 24,809 | $51.1K | 0.00% |
| FMR LLC | 17 | $35 | 0.00% |
Sold out (3)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 11,780 | $21.2K |
| Simplex Trading, LLC | 3,223 | $5.00K |
| Bank of America Corp | 15 | $27 |